PROCEPT BioRobotics (PRCT) Notes Payables (2023 - 2025)

PROCEPT BioRobotics (PRCT) has 3 years of Notes Payables data on file, last reported at $2.0 million in Q1 2025.

• On a quarterly basis, Notes Payables rose 4.49% year-over-year to $2.0 million in Q1 2025; TTM through Mar 2025 was $2.0 million, a 4.49% increase from a year earlier, with the FY2024 full-year figure at $2.0 million, up 6.04% from the prior year.
• Notes Payables for Q1 2025 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
• Over the last five years, Notes Payables for PRCT reached as high as $2.0 million in Q3 2024 and fell as low as $1.9 million in Q4 2023.
• Historically, Notes Payables has averaged $2.0 million across 3 years, with a median of $2.0 million in 2024.
• Across the five-year window, Notes Payables rose 6.04% in 2024 and gained 4.49% in 2025, its largest moves.
• Year by year, Notes Payables stood at $1.9 million in 2023, then increased by 6.04% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
• Per Business Quant data, the three most recent Notes Payables figures were $2.0 million in Q1 2025, $2.0 million in Q4 2024, and $2.0 million in Q3 2024.